VanNieuwenhze Michael S, Mauldin Scott C, Zia-Ebrahimi Mohammad, Winger Brian E, Hornback William J, Saha Shankar L, Aikins James A, Blaszczak Larry C
Discovery Chemistry Research and the Department of Pharmaceutical and Analytical Chemistry, Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
J Am Chem Soc. 2002 Apr 10;124(14):3656-60. doi: 10.1021/ja017386d.
Bacterial peptidoglycan is composed of a network of beta-[1,4]-linked glyan strands that are cross-linked through pendant peptide chains. The final product, the murein sacculus, is a single, covalently closed macromolecule that precisely defines the size and shape of the bacterial cell. The recent increase in bacterial resistance to cell wall active agents has led to a resurgence of activity directed toward improving our understanding of the resistance mechanisms at the molecular level. The biosynthetic enzymes and their natural substrates can be invaluable tools in this endeavor. While modern experimental techniques have led to isolation and purification of the biosynthetic enzymes utilized in peptidoglycan biosynthesis, securing useful quantities of their requisite substrates from natural substrates has remained problematic. In an effort to address this issue, we report the first total synthesis of lipid II (4), the final monomeric intermediate utilized by Gram positive bacteria for peptidoglycan biosynthesis.
细菌肽聚糖由β-[1,4]-连接的聚糖链网络组成,这些聚糖链通过侧链肽链交联。最终产物,即胞壁质囊泡,是一个单一的、共价闭合的大分子,精确地定义了细菌细胞的大小和形状。最近细菌对细胞壁活性剂的耐药性增加,导致人们重新致力于在分子水平上更好地理解耐药机制。生物合成酶及其天然底物可能是这一研究中的宝贵工具。虽然现代实验技术已实现了肽聚糖生物合成中所用生物合成酶的分离和纯化,但从天然底物中获取足量的所需底物仍然存在问题。为了解决这个问题,我们报告了脂质II(4)的首次全合成,脂质II是革兰氏阳性菌用于肽聚糖生物合成的最终单体中间体。